Waters Corporation (WAT) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Waters Corporation · Health Care · ref. ETF XLV · 50 calls · price $421.26
What the company does: Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe.
📈 Waters Corporation (WAT) stock price
$421.26+41.5% over range
Aug 28, 25low $283.32 · high $421.26Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
53% recommend buying · 15 analysts
📊 JPI status : Waters Corporation has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
⚠️ The stock trades above the median target: it has beaten expectations. The “Buy” reflects conviction on the company, but the remaining quantified upside is low/negative.
🎯 WAT price target & analyst consensus — price $421
The price target · all analysts combined (15 targets)
Highest target · 2 firms of 15$475+12.8%
Median target · of 15 targets$420-0.3%
Lowest target · 1 firm of 15$330-21.7%
Current price$421.26
Where these 15 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
747%
$425 ↔ $475
Below
853%
$330 ↔ $420
⏳ Targets haven't kept up with the price. 53% of ratings say “Buy”, yet 8 of 15 targets sit below the current price: the stock has risen past what analysts were aiming for, and some haven't raised their target yet. Read it as a dated view, not as a forecast of a drop.
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Morgan Stanley — 69% of its targets hit on this sector (825 calls tested). It aims for $390 (-7.4 %), call made on July 10, 2026, maturing on July 10, 2027 (49 d ago).
The 9 reliable analysts
$425+0.9 %
The 6 other firms
$398-5.6 %
How to read it: the 9 reliable firms are not filtered by optimism — 5 aim above the price, 4 below, hence their $425 median. “The 6 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 15 ratings (last 6 months)
Strong Buy00%
Buy853%
Hold747%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 WAT price target all
All 14 calls, one by one, with our verdict on each firm.
→ See all 14 targets, analyst by analyst💡 The best analysts on WAT most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in WAT? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Waters Corporation? The JPI assistant answers using our backtest data.
📈 Waters Corporation fundamentals: valuation, margins & growth › open the full page
P/E 105.3Net margin 3.6 %Revenue growth +113.4 %Cheap for the growth
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 24 %
2023
Rev −1%Profit −9%
2024
Rev +0%Profit −1%
2025
Rev +7%Profit +1%
🏛️ Waters Corporation insider buying: who's buying and how much › open the full page
2 insiders bought2 buys / 6 mo $451k👥 Cluster buy
🔎 Detailed analyses
✅ Historical analyst reliability on WAT
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Baird ↗ | 67% | +2.8% | 9 |
| Morgan Stanley ↗ | 60% | +1.9% | 5 |
| Jefferies ↗ | 50% | +17.4% | 2 |
| Goldman Sachs ↗ | 50% | -3.4% | 2 |
| Barclays ↗ | 43% | -5.9% | 21 |
| Evercore ISI Group ↗ | 33% | +0.6% | 3 |
| B of A Securities ↗ | 25% | -15.7% | 4 |
| Wells Fargo ↗ | 12% | -15.5% | 8 |
| Citigroup ↗ | 0% | -56.6% | 4 |
📊 What $1,000 invested in Waters Corporation would be worth › open the full page
In short — $1,000 invested in Waters Corporation 10 years ago would be worth $2,787 today, i.e. +11%/yr on average. Best year: 2021 (+51%), worst: 2022 (-8%). Price performance, excluding dividends.
If I'd invested $1,000 in Waters Corporation
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,011 | +1% |
| 3 years ago | $1,095 | +9% |
| 5 years ago | $1,516 | +52% |
Return by year (Waters Corporation)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -1% | $987 (-1%) |
| 2025 | +2% | $1,011 (+1%) |
| 2024 | +13% | $1,139 (+14%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Waters Corporation
Loading news…
📋 All analyst calls on WAT
Filtered on — · ✕ show all
▲ Buy · 🎯$470
Price at call : $415 — upside +13%
Today : $421.26 — upside +12%
🎯 on WAT : no call matured yet · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Aug 10, 27
matures : Aug 10, 27
▲ Buy · 🎯$475
Price at call : $399.7 — upside +19%
Today : $421.26 — upside +13%
🎯 on WAT : no call matured yet · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Aug 5, 27
matures : Aug 5, 27
RBC Capital ↗
Aug 5, 26
▲ Outperform · 🎯$475
Price at call : $399.7 — upside +19%
Today : $421.26 — upside +13%
🎯 on WAT : no call matured yet · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Aug 5, 27
matures : Aug 5, 27
Evercore ISI Group ↗
Aug 5, 26
▲ Outperform · 🎯$420
Price at call : $399.7 — upside +5%
Today : $421.26 — upside -0%
🎯 on WAT : no call matured yet · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Aug 5, 27
matures : Aug 5, 27
Wells Fargo ↗
Aug 5, 26
■ Equal-Weight neutral · not a buy · 🎯$400
Price at call : $399.7 — gap to target +0%
Today : $421.26 — gap to target -5%
🎯 on WAT : 0% (1 call matured) · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Aug 5, 27
matures : Aug 5, 27
▲ Overweight · 🎯$460
Price at call : $399.7 — upside +15%
Today : $421.26 — upside +9%
🎯 on WAT : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Aug 5, 27
matures : Aug 5, 27
Goldman Sachs ↗
Jul 14, 26
▲ Buy · 🎯$425
Price at call : $374.92 — upside +13%
Today : $421.26 — upside +1%
🎯 on WAT : no call matured yet · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : Jul 14, 27
matures : Jul 14, 27
Morgan Stanley ↗
Jul 9, 26
■ Equal-Weight neutral · not a buy · 🎯$390
Price at call : $376.43 — gap to target +4%
Today : $421.26 — gap to target -7%
🎯 on WAT : no call matured yet · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Jul 9, 27
matures : Jul 9, 27
See the other 42 calls, newest to oldest
RBC Capital ↗
Jul 9, 26
▲ Outperform · 🎯$435
Price at call : $376.43 — upside +16%
Today : $421.26 — upside +3%
🎯 on WAT : no call matured yet · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Jul 9, 27
matures : Jul 9, 27
Guggenheim ↗
Jul 8, 26
▲ Buy · 🎯$440
Price at call : $368.13 — upside +20%
Today : $421.26 — upside +4%
🎯 on WAT : no call matured yet · 📊 on Health : 54.6% · +4.4% (97 calls)
in progress (365j)
matures : Jul 8, 27
matures : Jul 8, 27
Evercore ISI Group ↗
Jul 6, 26
▲ Outperform · 🎯$410
Price at call : $374.93 — upside +9%
Today : $421.26 — upside -3%
🎯 on WAT : no call matured yet · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Jul 6, 27
matures : Jul 6, 27
Piper Sandler ↗
Jun 11, 26
■ Neutral neutral · not a buy · 🎯$400
Price at call : $359.74 — gap to target +11%
Today : $421.26 — gap to target -5%
🎯 on WAT : no call matured yet · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Jun 11, 27
matures : Jun 11, 27
▲ Buy · 🎯$435
Price at call : $376.47 — upside +16%
Today : $421.26 — upside +3%
🎯 on WAT : no call matured yet · 📊 on Health : 53.6% · +1.4% (28 calls)
in progress (365j)
matures : Jun 3, 27
matures : Jun 3, 27
B of A Securities ↗
Jun 2, 26
■ Neutral neutral · not a buy · 🎯$400
Price at call : $379.77 — gap to target +5%
Today : $421.26 — gap to target -5%
🎯 on WAT : no call matured yet · 📊 on Health : 48.3% · +2.0% (356 calls)
in progress (365j)
matures : Jun 2, 27
matures : Jun 2, 27
Wells Fargo ↗
May 14, 26
■ Equal-Weight neutral · not a buy · 🎯$370
Price at call : $329.22 — gap to target +12%
Today : $421.26 — gap to target -12%
🎯 on WAT : 0% (1 call matured) · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : May 14, 27
matures : May 14, 27
▲ Overweight · 🎯$425
Price at call : $355.13 — upside +20%
Today : $421.26 — upside +1%
🎯 on WAT : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
■ Neutral neutral · not a buy · 🎯$375
Price at call : $350.49 — gap to target +7%
Today : $421.26 — gap to target -11%
🎯 on WAT : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
■ Neutral neutral · not a buy · 🎯$345
Price at call : $350.49 — gap to target -2%
Today : $421.26 — gap to target -18%
🎯 on WAT : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
■ Hold neutral · not a buy · 🎯$385
Price at call : $350.49 — gap to target +10%
Today : $421.26 — gap to target -9%
🎯 on WAT : no call matured yet · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
■ Neutral neutral · not a buy · 🎯$330
Price at call : $330.98 — gap to target -0%
Today : $421.26 — gap to target -22%
🎯 on WAT : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Apr 13, 27
matures : Apr 13, 27
Deutsche Bank ↗
Mar 25, 26
■ Hold neutral · not a buy · 🎯$330
Price at call : $300.56 — gap to target +10%
Today : $421.26 — gap to target -22%
🎯 on WAT : no call matured yet · 📊 on Health : 53.3% · +4.5% (291 calls)
in progress (365j)
matures : Mar 25, 27
matures : Mar 25, 27
Morgan Stanley ↗
Feb 23, 26
■ Equal-Weight neutral · not a buy · 🎯$350
Price at call : $326.3 — gap to target +7%
Today : $421.26 — gap to target -17%
🎯 on WAT : no call matured yet · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Feb 23, 27
matures : Feb 23, 27
Wells Fargo ↗
Feb 11, 26
■ Equal-Weight neutral · not a buy · 🎯$355
Price at call : $319.83 — gap to target +11%
Today : $421.26 — gap to target -16%
🎯 on WAT : 0% (1 call matured) · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Feb 11, 27
matures : Feb 11, 27
■ Neutral neutral · not a buy · 🎯$370
Price at call : $329.2 — gap to target +12%
Today : $421.26 — gap to target -12%
🎯 on WAT : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Feb 10, 27
matures : Feb 10, 27
Guggenheim ↗
Feb 10, 26
▲ Buy · 🎯$440
Price at call : $327.02 — upside +35%
Today : $421.26 — upside +4%
🎯 on WAT : no call matured yet · 📊 on Health : 54.6% · +4.4% (97 calls)
in progress (365j)
matures : Feb 10, 27
matures : Feb 10, 27
B of A Securities ↗
Feb 10, 26
■ Neutral neutral · not a buy · 🎯$350
Price at call : $327.02 — gap to target +7%
Today : $421.26 — gap to target -17%
🎯 on WAT : no call matured yet · 📊 on Health : 48.3% · +2.0% (356 calls)
in progress (365j)
matures : Feb 10, 27
matures : Feb 10, 27
▲ Buy · 🎯$460
Price at call : $390.09 — upside +18%
Today : $421.26 — upside +9%
🎯 on WAT : no call matured yet · 📊 on Health : 53.6% · +1.4% (28 calls)
in progress (365j)
matures : Jan 27, 27
matures : Jan 27, 27
William Blair ↗
Jan 5, 26
▲ Outperform
🎯 on WAT : no call matured yet · 📊 on Health : 63% · +5.2% (27 calls)
in progress (365j)
matures : Jan 5, 27
matures : Jan 5, 27
Wells Fargo ↗
Dec 15, 25
■ Equal-Weight neutral · not a buy · 🎯$415
Price at call : $378.53 — gap to target +10%
Today : $421.26 — gap to target -1%
🎯 on WAT : 0% (1 call matured) · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Dec 15, 26
matures : Dec 15, 26
Wolfe Research ↗
Dec 10, 25
▲ Outperform · 🎯$480
Price at call : $392.21 — upside +22%
Today : $421.26 — upside +14%
🎯 on WAT : no call matured yet · 📊 on Health : 60.9% · +4.3% (46 calls)
in progress (365j)
matures : Dec 10, 26
matures : Dec 10, 26
Morgan Stanley ↗
Dec 2, 25
■ Equal-Weight neutral · not a buy · 🎯$423
Price at call : $397.62 — gap to target +6%
Today : $421.26 — gap to target +0%
🎯 on WAT : no call matured yet · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Dec 2, 26
matures : Dec 2, 26
■ Hold neutral · not a buy · 🎯$390
Price at call : $371.16 — gap to target +5%
Today : $421.26 — gap to target -7%
🎯 on WAT : no call matured yet · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Nov 5, 26
matures : Nov 5, 26
Wells Fargo ↗
Nov 5, 25
■ Equal-Weight neutral · not a buy · 🎯$385
Price at call : $371.16 — gap to target +4%
Today : $421.26 — gap to target -9%
🎯 on WAT : 0% (1 call matured) · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Nov 5, 26
matures : Nov 5, 26
■ Neutral neutral · not a buy · 🎯$325
Price at call : $331 — gap to target -2%
Today : $421.26 — gap to target -23%
🎯 on WAT : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Oct 9, 26
matures : Oct 9, 26
Rothschild & Co
Oct 8, 25
▲ Buy · 🎯$390
Price at call : $327.65 — upside +19%
Today : $421.26 — upside -7%
🎯 on WAT : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Oct 8, 26
matures : Oct 8, 26
Deutsche Bank ↗
Aug 5, 25
■ Hold neutral · not a buy · 🎯$315
Price at call : $277.72 — gap to target +13%
Today : $421.26 — gap to target -25%
🎯 on WAT : no call matured yet · 📊 on Health : 53.3% · +4.5% (291 calls)
in progress (365j)
matures : Aug 5, 26
matures : Aug 5, 26
Wells Fargo ↗
Aug 5, 25
■ Equal-Weight neutral · not a buy · 🎯$315
Price at call : $277.72 — gap to target +13%
Today : $421.26 — gap to target -25%
🎯 on WAT : 0% (1 call matured) · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Aug 5, 26
matures : Aug 5, 26
▲ Buy · 🎯$385
Price at call : $281.19 — upside +37%
Today : $421.26 — upside -9%
Expected +37% · Actual +42% · Reason (≥ +15%) : ✓ Yes
🎯 on WAT : 100% (1 call matured) · 📊 on Health : 50.8% · +4.5% (380 calls)
+42.3%
stock +42% · XLV +24%
matured Aug 4, 26
▲ Outperform · 🎯$352
Price at call : $289.56 — upside +22%
Today : $421.26 — upside -16%
Expected +22% · Actual +31% · Reason (≥ +15%) : ✓ Yes
🎯 on WAT : 75% (4 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
+30.6%
stock +31% · XLV +21%
matured Jul 16, 26
Wells Fargo ↗
Jul 15, 25
■ Equal-Weight neutral · not a buy · 🎯$330
Price at call : $289.56 — gap to target +14%
Today : $421.26 — gap to target -22%
🎯 on WAT : 0% (1 call matured) · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Jul 15, 26
matures : Jul 15, 26
B of A Securities ↗
Jun 26, 25
■ Neutral neutral · not a buy · 🎯$375
Price at call : $352.41 — gap to target +6%
Today : $421.26 — gap to target -11%
🎯 on WAT : no call matured yet · 📊 on Health : 48.3% · +2.0% (356 calls)
in progress (365j)
matures : Jun 26, 26
matures : Jun 26, 26
▲ Outperform · 🎯$374
Price at call : $350.88 — upside +7%
Today : $421.26 — upside -11%
Expected +7% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on WAT : 75% (4 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
+1.2%
stock +1% · XLV +7%
matured May 7, 26
■ Neutral neutral · not a buy · 🎯$360
Price at call : $350.88 — gap to target +3%
Today : $421.26 — gap to target -15%
🎯 on WAT : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : May 7, 26
matures : May 7, 26
▲ Outperform · 🎯$355
Price at call : $330.71 — upside +7%
Today : $421.26 — upside -16%
Expected +7% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on WAT : 75% (4 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
+1.1%
stock +1% · XLV +8%
matured Apr 22, 26
■ Equal-Weight neutral · not a buy · 🎯$350
Price at call : $325.22 — gap to target +8%
Today : $421.26 — gap to target -17%
🎯 on WAT : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Apr 10, 26
matures : Apr 10, 26
▲ Overweight · 🎯$460
Price at call : $356 — upside +29%
Today : $421.26 — upside +9%
Expected +29% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on WAT : 0% (1 call matured) · 📊 on Health : 44.1% · -1.7% (143 calls)
-15.8%
stock -16% · XLV +3%
matured Mar 31, 26
▲ Outperform · 🎯$407
Price at call : $367.79 — upside +11%
Today : $421.26 — upside -3%
Expected +11% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on WAT : 75% (4 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
-18.3%
stock -18% · XLV +1%
matured Mar 26, 26
■ Neutral neutral · not a buy · 🎯$390
Price at call : $392.99 — gap to target -1%
Today : $421.26 — gap to target -7%
🎯 on WAT : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Mar 6, 26
matures : Mar 6, 26
Scotiabank ↗
Feb 13, 25
▲ Sector Outperform · 🎯$450
Price at call : $369.73 — upside +22%
Today : $421.26 — upside +7%
Expected +22% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on WAT : 0% (1 call matured) · 📊 on Health : 33.3% · -8.8% (9 calls)
-13.1%
stock -13% · XLV +9%
matured Feb 13, 26
Wells Fargo ↗
Feb 13, 25
▲ Overweight · 🎯$420
Price at call : $369.73 — upside +14%
Today : $421.26 — upside -0%
Expected +14% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on WAT : 0% (1 call matured) · 📊 on Health : 48.5% · +1.2% (392 calls)
-13.1%
stock -13% · XLV +9%
matured Feb 13, 26
Frequently asked questions
Should I buy Waters Corporation stock?
This isn't buy advice. For Waters Corporation, the analyst consensus is "Buy", with an average price target of $420 (0% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 67% of the time (9 calls tracked on Waters Corporation). We show the numbers — you decide.
Is it too late to buy Waters Corporation? How high can it go?
The most bullish analyst target on Waters Corporation is $475 (+13% above today's price); the average is $420. That's the upside they see. Check how reliable those analysts have actually been on Waters Corporation on our site before trusting it.
Is Waters Corporation still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 9 analysts have a real record on Waters Corporation, the best hitting 67% over 9 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Waters Corporation? The case for and against
The arguments for and against, one by one, from the numbers: why invest in WAT (and why hesitate).
What has Waters Corporation's past performance been?
Historical returns and a "how much if I had invested" calculator: WAT performance & returns.
Are insiders buying WAT stock?
Executives' and large holders' buys and sells, decoded: insider buying on WAT.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX